Ogerin

CAS No. 1309198-71-7

Ogerin ( —— )

Catalog No. M23467 CAS No. 1309198-71-7

Ogerin is a selective GPR68 positive allosteric modulator (pEC50: 6.83). Ogerin blocks recall in fear conditioning in mice.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 61 In Stock
10MG 105 In Stock
25MG 215 In Stock
50MG 361 In Stock
100MG 537 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ogerin
  • Note
    Research use only, not for human use.
  • Brief Description
    Ogerin is a selective GPR68 positive allosteric modulator (pEC50: 6.83). Ogerin blocks recall in fear conditioning in mice.
  • Description
    Ogerin is a selective GPR68 positive allosteric modulator (pEC50: 6.83). Ogerin blocks recall in fear conditioning in mice. Ogerin displays inverse agonist and antagonist activity (Ki, 220 nM) at A2A receptor and weak antagonist activity (Ki, 736 nM) at 5-HT2B receptor.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT2B;A2A;GPR68
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1309198-71-7
  • Formula Weight
    307.4
  • Molecular Formula
    C17H17N5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL (813.40 mM; Need ultrasonic)
  • SMILES
    OCC1=C(C2=NC(N)=NC(NCC3=CC=CC=C3)=N2)C=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Huang XP, et al. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature. 2015 Nov 26;527(7579):477-83.
molnova catalog
related products
  • RS 127445

    RS 127445 is a selective high affinity orally bioavailable 5-HT2B receptor antagonist(pKi : 9.5).

  • AC-90179 HCl

    AC-90179 HCl is a selective inverse agonist of 5-HT2A receptor. AC-90179 HCl is an atypical antipsychotic pharmaceutical and has been shown to alleviate hallucinogen-induced vasocontriction.

  • glucosylvitexin

    Glucosylvitexin inhibits TPO activity.